Human Dermal Fibroblast Isolation via Surface Marker Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively separate and characterize human dermal fibroblast subpopulations based on distinct cell surface markers, hindering their use in treating skin conditions and wound healing.
Innovation Solution
A method involving the separation of human dermal fibroblasts into subpopulations using specific cell-surface markers such as CD39, CD36, and CD26, employing techniques like flow cytometry, magnetic beads, and microfluidics, to identify and isolate papillary and reticular fibroblasts, which can be expanded in culture while retaining functional properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mechanical separation of papillary and reticular dermis is performed, then fibroblast subpopulations can be separated, but cell surface markers that permit prospective isolation cannot be identified
Solution Approach 1:
The invention segments the dermis into papillary and reticular layers, and further segments fibroblasts into distinct subpopulations based on cell surface marker expression patterns. This multi-level segmentation enables both physical separation and molecular characterization of fibroblast heterogeneity.
Solution Approach 2:
The invention uses fluorescently labeled antibodies that bind to specific cell surface markers (CD39, CD36, CD26, CD90), creating detectable signal changes that allow identification and sorting of different fibroblast subpopulations based on their marker expression profiles.
2Ease of operation
If flow cytometry is used to separate fibroblasts based on cell surface markers, then prospective isolation of subpopulations is achieved, but functional properties may be lost during expansion
Solution Approach 1:
The invention performs preliminary characterization of cell surface markers on freshly isolated fibroblasts before expansion, establishing baseline marker expression profiles. This allows monitoring of marker retention during expansion and selection of appropriate culture conditions to maintain both functional properties and marker expression.
Solution Approach 2:
The invention implements feedback monitoring of cell surface marker expression during in vitro expansion, using this information to adjust culture conditions and passage strategies to maintain both functional properties and marker fidelity of isolated fibroblast subpopulations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the isolation and expansion of functionally distinct fibroblast subpopulations, enabling their use in treating skin disorders, promoting wound healing, and reducing scarring, with potential applications in cosmetic and therapeutic methods.
Implementation Method 1
the human dermal fibroblasts are separated by flow cytometry
Implementation Method 2
the human dermal fibroblasts are separated using magnetic beads, columns and/or microfluidics
Data Source
AI summary
Provided herein is a method of sorting human dermal fibroblasts, comprising (a) providing a cell population comprising human dermal fibroblasts; and (b) separating the human dermal fibroblasts into subpopulations based on expression of one or more cell-surface markers selected from CD39, CD36 and CD26. Also provided are isolated populations of human dermal papillary fibroblasts and cosmetic and therapeutic uses thereof.